Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Goda Baddage Rakitha Malewana"'
Autor:
William E. Matchett, Stephanie Anguiano-Zarate, Goda Baddage Rakitha Malewana, Haley Mudrick, Melissa Weldy, Clayton Evert, Alexander Khoruts, Michael Sadowsky, Michael A. Barry
Publikováno v:
Vaccines, Vol 8, Iss 3, p 470 (2020)
Clostridium difficile causes nearly 500,000 infections and nearly 30,000 deaths each year in the U.S., which is estimated to cost $4.8 billion. C. difficile infection (CDI) arises from bacteria colonizing the large intestine and releasing two toxins,
Externí odkaz:
https://doaj.org/article/f00be2bc33194d98a768b053726c0cbb
Autor:
William E. Matchett, Goda Baddage Rakitha Malewana, Haley Mudrick, Michael J. Medlyn, Michael A. Barry
Publikováno v:
Vaccines, Vol 8, Iss 1, p 64 (2020)
Most infections occur at mucosal surfaces. Providing a barrier of protection at these surfaces may be a useful strategy to combat the earliest events in infection when there are relatively few pathogens to address. The majority of vaccines are delive
Externí odkaz:
https://doaj.org/article/b2d0e0b47e7f4637b2557262bc7bd90f
Autor:
Clayton Evert, Alexander Khoruts, Goda Baddage Rakitha Malewana, Michael J. Sadowsky, Michael A. Barry, Stephanie S. Anguiano-Zarate, William E. Matchett, Melissa Weldy, Haley Mudrick
Publikováno v:
Vaccines
Volume 8
Issue 3
Vaccines, Vol 8, Iss 470, p 470 (2020)
Volume 8
Issue 3
Vaccines, Vol 8, Iss 470, p 470 (2020)
Clostridium difficile causes nearly 500,000 infections and nearly 30,000 deaths each year in the U.S., which is estimated to cost $4.8 billion. C. difficile infection (CDI) arises from bacteria colonizing the large intestine and releasing two toxins,
Autor:
Goda Baddage Rakitha Malewana, Haley Mudrick, William E. Matchett, Michael A. Barry, Michael J. Medlyn
Publikováno v:
Vaccines
Volume 8
Issue 1
Vaccines, Vol 8, Iss 1, p 64 (2020)
Volume 8
Issue 1
Vaccines, Vol 8, Iss 1, p 64 (2020)
Most infections occur at mucosal surfaces. Providing a barrier of protection at these surfaces may be a useful strategy to combat the earliest events in infection when there are relatively few pathogens to address. The majority of vaccines are delive